Literature DB >> 6664382

Evidence for mediation by 5-HT2 receptors of 5-hydroxytryptamine-induced contraction of canine basilar artery.

E Müller-Schweinitzer, G Engel.   

Abstract

The agonist potencies of 8 indole derivatives and the potencies of 19 recognized antagonists to inhibit constrictor responses to 5-hydroxytryptamine (5-HT) of canine basilar artery were established. In addition the affinities of the indole derivatives for [3H]5-hydroxytryptamine [( 3H]5-HT) binding sites and the affinities of the antagonists for [125Iodo]LSD [( 125I]LSD) binding sites in rat brain cortex membranes were determined. Comparison was also made between the potencies of the antagonists on canine basilar artery and the KD values published for displacement of [3H]ketanserin binding (Leysen et al. 1982). There was a good correlation between the affinities of the antagonists for 5-HT2 binding sites labelled by both [125I]LSD and [3H]ketanserin and the affinity parameters calculated for inhibition of constrictor responses to 5-HT of canine basilar artery. No correlation could be found between the affinities of the indole derivatives for 5-HT1 binding sites labelled by [3H]5-HT and their potencies to constrict canine basilar artery. It is concluded that constrictor responses to 5-HT of canine basilar artery are mediated by 5-HT2-like receptors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6664382     DOI: 10.1007/bf00502625

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  16 in total

1.  Analysis of the effect of 5-hydroxykynurenamine,, a serotonin metabolite, on isolated cerebral arteries, aortas and atria.

Authors:  N Toda
Journal:  J Pharmacol Exp Ther       Date:  1975-05       Impact factor: 4.030

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Ketanserin--a novel antihypertensive drug?

Authors:  P P Humphrey; W Feniuk; A D Watts
Journal:  J Pharm Pharmacol       Date:  1982-08       Impact factor: 3.765

4.  Serotonin receptor binding sites affected differentially by guanine nucleotides.

Authors:  S J Peroutka; R M Lebovitz; S H Snyder
Journal:  Mol Pharmacol       Date:  1979-11       Impact factor: 4.436

5.  [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.

Authors:  J E Leysen; C J Niemegeers; J M Van Nueten; P M Laduron
Journal:  Mol Pharmacol       Date:  1982-03       Impact factor: 4.436

6.  Evidence for 5-HT2 receptors mediating contraction in vascular smooth muscle.

Authors:  M L Cohen; R W Fuller; K S Wiley
Journal:  J Pharmacol Exp Ther       Date:  1981-08       Impact factor: 4.030

7.  Serotonin antagonism in isolated canine cerebral arteries.

Authors:  N Toda; S Hayashi; W L Fu; Y Nagasaka
Journal:  Jpn J Pharmacol       Date:  1976-02

8.  Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.

Authors:  J M Van Nueten; P A Janssen; J Van Beek; R Xhonneux; T J Verbeuren; P M Vanhoutte
Journal:  J Pharmacol Exp Ther       Date:  1981-07       Impact factor: 4.030

9.  Serotonin-induced contraction of canine basilar artery: mediation by 5-HT1 receptors.

Authors:  S J Peroutka; M Noguchi; D J Tolner; G S Allen
Journal:  Brain Res       Date:  1983-01-24       Impact factor: 3.252

10.  Serotoninergic receptors in brain tissue: properties and identification of various 3H-ligand binding sites in vitro.

Authors:  J E Leysen
Journal:  J Physiol (Paris)       Date:  1981
View more
  13 in total

1.  Central serotonin receptors: effector systems, physiological roles and regulation.

Authors:  P J Conn; E Sanders-Bush
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Characterization of 5-HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5-HT1-like receptor agonist.

Authors:  H E Connor; W Feniuk; P P Humphrey
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

3.  Influence of the endothelium on contractile effects of 5-hydroxytryptamine and selective 5-HT agonists in canine basilar artery.

Authors:  H E Connor; W Feniuk
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

4.  Venoconstrictor responses to dihydroergocristine and dihydroergotamine: evidence for the involvement of 5-HT1 like receptors.

Authors:  E Müller-Schweinitzer
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

5.  Effects of MDL 72222 and methiothepin on carotid vascular responses to 5-hydroxytryptamine in the pig: evidence for the presence of "5-hydroxytryptamine1-like" receptors.

Authors:  P R Saxena; D J Duncker; A H Bom; J Heiligers; P D Verdouw
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

6.  5-Carboxamide tryptamine, a compound with high affinity for 5-hydroxytryptamine1 binding sites, dilates arterioles and constricts arteriovenous anastomoses.

Authors:  P R Saxena; P D Verdouw
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

7.  2-[125Iodo]LSD, a new ligand for the characterisation and localisation of 5-HT2 receptors.

Authors:  G Engel; E Müller-Schweinitzer; J M Palacios
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-04       Impact factor: 3.000

Review 8.  Serotonin and the vascular system. Role in health and disease, and implications for therapy.

Authors:  D S Houston; P M Vanhoutte
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

9.  Ketanserin causes surmountable antagonism of 5-hydroxytryptamine-induced contractions of large coronary arteries of dog.

Authors:  M Frenken; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-01       Impact factor: 3.000

10.  Evidence for the existence of 5-hydroxytryptamine receptors, which are not of the 5-HT2 type, mediating contraction of rabbit isolated basilar artery.

Authors:  P B Bradley; P P Humphrey; R H Williams
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.